Monash IVF Group Executive and Leadership Team

Malik Jainudeen, the Acting Chief Executive Officer at Monash IVF Group, directs the overarching corporate strategy and operational continuity for the organization. Jainudeen manages the transition of executive priorities while maintaining the high standards of assisted reproductive technology services provided across the Oceania region. By coordinating with the Board and senior leadership, the Acting Chief Executive Officer ensures that clinical excellence remains the primary focus during periods of organizational change. Malik Jainudeen monitors financial performance and market positioning to sustain the competitive advantage of the company in the fertility sector. This leadership role involves balancing immediate operational requirements with long-term growth objectives. Through rigorous oversight of internal processes, the Acting Chief Executive Officer stabilizes the business model, ensuring that all diagnostic health services and fertility treatments continue to meet the complex needs of patients seeking advanced reproductive care.

Michael Knaap, the Chief Executive Officer & Managing Director at Monash IVF Group, architects the long-term vision and expansion strategy for the enterprise. Knaap oversees the integration of advanced reproductive technologies into the broader clinical framework, driving growth across the Australian market and beyond. The Chief Executive Officer & Managing Director aligns corporate governance with the mission of providing comprehensive fertility solutions, ensuring that the organization maintains its status as a pioneer in the field. Michael Knaap engages with stakeholders to secure the financial health and operational scalability of the group. By fostering a culture of innovation, the Chief Executive Officer & Managing Director supports the development of new diagnostic health services. This executive role requires constant evaluation of market trends and regulatory environments to maintain the leadership position of the company within the highly specialized fertility treatment industry.

Victoria Atkinson, the Chief Executive Officer, Monash IVF at Monash IVF Group, manages the clinical delivery and patient care standards across the network. Atkinson drives the implementation of specialized fertility treatments, ensuring that every clinic adheres to the rigorous scientific protocols established by the organization. The Chief Executive Officer, Monash IVF oversees the performance of medical teams and the deployment of reproductive technologies to optimize success rates for patients. Victoria Atkinson collaborates with clinical directors to refine diagnostic health services and improve the overall patient experience. By focusing on operational efficiency within the clinical environment, the Chief Executive Officer, Monash IVF supports the expansion of services throughout the Oceania region. This leadership position demands a deep understanding of both medical requirements and business operations to ensure that the company remains at the forefront of assisted reproductive technology.

Birol Akdogan, the Interim Chief Financial Officer at Monash IVF Group, manages the financial planning, reporting, and capital allocation strategies for the organization. Akdogan oversees the fiscal health of the company, ensuring that resources are directed toward high-impact fertility treatments and diagnostic health services. The Interim Chief Financial Officer monitors cash flow and budgetary compliance across the Oceania network to support sustainable growth. Birol Akdogan provides the executive team with financial insights that inform strategic decision-making regarding investments in new reproductive technologies. By maintaining rigorous financial controls, the Interim Chief Financial Officer ensures the stability of the business model during periods of expansion. This role involves managing investor relations and ensuring transparency in financial reporting. Through precise financial management, the Interim Chief Financial Officer supports the long-term viability of the company and its mission to provide comprehensive fertility solutions.

Rebecca Redden, the Chief Operating Officer at Monash IVF Group, directs the daily operational workflows and resource allocation across the entire clinic network. Redden manages the logistics of fertility treatment delivery, ensuring that facilities operate at peak efficiency to meet patient demand. The Chief Operating Officer oversees the standardization of operational procedures to maintain consistent quality across all locations in Australia and beyond. Rebecca Redden coordinates with clinical and administrative teams to streamline the patient journey from initial consultation to treatment completion. By optimizing supply chain management for reproductive technologies, the Chief Operating Officer supports the overall productivity of the organization. This role involves monitoring key performance indicators to identify areas for operational improvement and cost management. Through rigorous oversight of facility operations, the Chief Operating Officer ensures that the company delivers high-quality diagnostic health services in a reliable and scalable manner.

Fiona Allen, the Chief Marketing Officer at Monash IVF Group, executes the brand strategy and patient engagement initiatives across all regional markets. Allen directs the communication of complex fertility solutions to prospective patients, ensuring that the value proposition of the company remains clear and accessible. The Chief Marketing Officer manages the digital presence and public relations efforts to strengthen the market position of the organization. Fiona Allen analyzes patient demographics and market data to tailor outreach programs that support the growth of diagnostic health services. By aligning marketing campaigns with clinical milestones, the Chief Marketing Officer ensures consistent messaging across the Oceania network. This role involves building trust with the community through transparent communication about reproductive technologies. Through strategic brand management, the Chief Marketing Officer drives patient acquisition and maintains the reputation of the company as a leader in fertility care.

Thierry Panthier, the Chief Information Officer at Monash IVF Group, architects the digital infrastructure and data security frameworks necessary for modern fertility treatment. Panthier oversees the implementation of advanced health information systems that support clinical decision-making and patient record management. The Chief Information Officer ensures that all technological platforms remain compliant with industry regulations while facilitating seamless communication between clinics. Thierry Panthier drives the digital transformation of diagnostic health services, enabling more efficient data analysis and improved patient outcomes. By managing the IT roadmap, the Chief Information Officer supports the scalability of the company across the Oceania region. This leadership role involves protecting sensitive patient data through robust cybersecurity measures and maintaining the reliability of critical medical software. Through continuous innovation in information technology, the Chief Information Officer enables the organization to maintain its competitive edge in the reproductive technology sector.

Jonathan Beever, the Interim Chief Information Officer at Monash IVF Group, directs the maintenance and optimization of the enterprise technology stack. Beever oversees the integration of new software solutions that enhance the delivery of diagnostic health services and fertility treatments. The Interim Chief Information Officer manages the technical support teams to ensure minimal downtime for critical clinical systems across the Oceania region. Jonathan Beever evaluates emerging technologies to determine their potential for improving patient care and operational efficiency. By focusing on system reliability and data integrity, the Interim Chief Information Officer supports the broader digital strategy of the organization. This role involves collaborating with other C-suite leaders to align technology investments with business objectives. Through the management of complex IT projects, the Interim Chief Information Officer ensures that the company maintains a secure and efficient digital environment for all clinical operations.

Marnie Kalinski, the Interim Chief People Officer at Monash IVF Group, directs the human resources strategy and talent management initiatives for the organization. Kalinski oversees the recruitment, retention, and professional development of the specialized medical and administrative staff required to deliver fertility treatments. The Interim Chief People Officer fosters a workplace culture that prioritizes clinical excellence and patient-centered care. Marnie Kalinski manages organizational design and workforce planning to ensure that clinics are adequately staffed across the Oceania region. By implementing performance management systems, the Interim Chief People Officer supports the growth and engagement of the workforce. This role involves navigating complex labor requirements and promoting diversity and inclusion within the company. Through strategic human capital management, the Interim Chief People Officer ensures that the organization attracts and retains the top talent necessary to maintain its leadership in the reproductive technology industry.